SPRY
ARS Pharmaceuticals, Inc.Healthcare$8.30
▲ Bullish
Mkt Cap: $824.2M|Float: 41.6M|SI: 57.1%|DTC: 21.2
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
86%
HV 20d
6291.0%
52W Range
$7-$19
ATR(14)
$0.59
Exp. Move
±22.3%
P/C Ratio
0.13
Earnings
May 14
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
SPRY Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $0.4M
- Max Pain
- $7.50
- Expected Move
- ±22.3%
- Put/Call OI
- 0.13
- Net Premium
- $0.6M
- Spot Price
- $8.30
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.85 | ±22.3% | $6.45 | $10.15 |
| 2026-06-18 | 77 | ±$4.78 | ±57.5% | $3.53 | $13.08 |
| 2026-09-18 | 169 | ±$4.15 | ±50.0% | $4.15 | $12.45 |
Explore SPRY options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.